C-a, also called biliary glycoprotein (BGP), is a member of the carcinoembryonic antigen (CEA) family and of the immunoglobulin superfamily. CD66a is the human homologue of Cell-CAM, a well-defined cell adhesion molecule of the rat. In the present study a monoclonal antibody specific for CD66a was used to locate CD66a in human tissues. CD66a is expressed in epithelia, in certain endothelia, and in cells ofthe myeloid lineage. Hepatocytes were stained along the bile canaliculi. A characteristic apical membranous staining was observed in enterocytes, superficial absorptive cells of the colon, in the epithelia of esophageal and Brunner's glands, bile ducts and gallbladder, pancreatic ducts, proximal tubules of the kidney, prostate, endometrium, and ' Supported by grant WA 47315-2 from the Deutsche Fonchungsgemeinschaft. Correspondence to: Prof. C. Wagener, Abteilung fur Klinische Chemie. Medizinische Klinik, Univenitatskrankenhaus Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany. mammary ducts. Selective staining of endothelia was present in glomeruli and vasa recta of the kidney, small placental vessels, adrenal sinusoids, endometrium, the prostate. Among the cells of the myeloid lineage, granulocytes and myelocytes were positive. The expression of CD66a by human cells and tissues is well comparable with the expression reported for Cell-CAM, the rat counterpart of CD66a. The wide tissue distribution of CD66a indicates that CD66a is a prominent human adhesion molecule. (J Hisrochem Cyrochem 44~35-41, 19%)
Introduction
CD66a, a member of the CD66 cluster of granulocyte differentiation antigens, belongs to the carcinoembryonic antigen (CEA) family and the immunoglobulin superfamily (1). Glycoproteins of the CEA family are expressed in epithelial tissues, such as colon mucosa, in addition to cells of the myeloid lineage (1). For several reasons, CD66a has been considered to function as a cell adhesion molecule. Transfectomas expressing CD66a mediate homophilic binding and heterophilic binding to other members of the CD66a family (2.3). Furthermore, CD66a has been reported to be the major carrier of sialyl Lex-oligosaccharides on human granulocytes (4). and it has been suggested that CD66a functions as a ligand for E-selectin (5). In addition, CD66a is the human homologue of Cell-CAM, a well-defined cell adhesion molecue of the rat (6,7). In comparison with other members of the CEA family, CD66a exhibits several distinct features. In contrast to most of the genes of the CEA family, the CD66a gene predicts a cytoplasmic domain that contains sequence motifs of molecules involved in signal transduction (8, 9) . Although no genes homologous to the CEA and other CD66 genes have been found in rats and mice, CD66a appears to be wellconserved during the evolution of vertebrates, indicating that CD66a serves important biological functions (1).
The location of Cell-CAM in rat tissues has been studied in great detail (10,ll). The adhesion molecule is expressed in a variety of epithelial tissues, in endothelial cells, and in platelets and cells of the myeloid lineage. Svenberg and co-workers (12) used a polyclonal antiserum against BGP to locate the antigen in the human gastrointestinal tract. However, as stated by the authors, the antisenun probably crossreacted with NCA. Furthermore, crossreactivity with products of the CEA gene family detected later, such as CD66a and CGM2, cannot be excluded. Recently, we reported on the char-acteritation of a monoclonal antibody (MAb) binding to CD66a, but not to any other antigen of the CD66 cluster for which the expression in human tissues has been documented (13-15). In the present study this MAb was used to specifically locate CD66a in a variety of human tissues. For comparison, CEA was stained by use of a specific MAb (16) (17) (18) (19) . Our results indicate that the expression of CD66a in human tissues is well comparable with published results on the expression of Cell-CAM in rat tissues.
Materials and Methods
Antibodies. Details of the isolation and characterization of MAb 4DliC2 and MAb T84.66 have been published previously (13, 14, 16, 17, 19) .
Tissue Samples and Cell Lines. Tissues for immunohistochemistry were collected from routinely processed, formalin-fixed and paraffin-embedded surgical specimens with normal conventional histology or minimal unspecific inflammation, fibrosis, or epithelial hyperplasia. Bone marrow was from autopsies performed within 48 hr after the patients' decease. For each organ (Table 1 ) two or more independent samples were collected. CEAtransfected HeLa cells (kindly provided by Dr. John Shively) were cultivated in MEM in the presence of 10% FCS on 3-aminopropyltriethoxysilane (APES)-coated slides and fixed in PBS-buffered formalin (4%) at 4°C for 20 min. Slides were dehydrated in graded ethanols and stored in air-tight boxes at -2O'C until used for immunocytochemistry within 2 weeks.
Granulocytes were isolated from buffy coat of normal donors by Ficoll-Paque gradient centrifugation (Pharmacia; Freiburg, Germany). Fresh normal colon tissue was obtained immediately after surgical removal; the mucosa was stripped from the underlying muscularis, minced in small pieces, and homogenized on ice.
SDS-PAGE and Western
Blots. Extraction of proteins from granulocytes and normal colon mucosa was carried out in the presence of 1% NP40 and protease inhibitors as described previously (14) . SDS-PAGE was performed in 7.5 % polyacrylamide gels under reducing conditions, applying equal amounts of concentrated protein extracts. After electrophoretic transfer to nitrocellulose (semi-dry blotter; Biometra, Gottingen, Germany) and blocking in TBS containing 5 % BSA for 2 hr, MAb 4DllC2 was added at a final concentration of 2 wg/ml and incubated overnight. Detection was carried out applying the chemiluminescent substrate and enhancer kit (Dianova; Hamburg, Germany). Films (Hyperfilm; Amersham, Braunschweig, Germany) were exposed for 10 min.
Immunohistochemistry. Sections (4 pm) were mounted on APES-coated slides, deparaffinized in xylene, and rehydrated in graded alcohols to TBS (50 mM Tris, 150 mM NaCI, pH 7.4). For antigen retrieval, control experiments showed microwave treatment according to Shi et al. (20) to be superior to pre-digestion with protease. Slides were microwaved five times for 2 min at 500 W in 10 mM citrate, pH 6.0, in a commercial kitchen microwave oven. After cooling for 20 min, slides were washed in TBS, blocked for 30 min at room temperature with normal goat serum (Dako; Glostrup, Denmark) diluted 1:20 in TBS, and incubated overnight at 4'C with 4DllC2 at 4 pglml or T84.66 at 2 pg/ml in TBS. Non-immune murine immunoglobulins (Dako) at equal concentrations were used as negative controls. Alkaline phosphatase-anti-alkaline phosphatase (APAAP) detection (Dako) and color development with new fuchsin were carried out according to standard procedures. The avidin-biotin complex (ABC) (Vector; Burlingame, CA) and color development with 3,3'-diaminobenzidine tetrahydrochloride (DAB) (Sigma; Deisenhofen, Germany) were employed on sections from the small intestine and the pyloric region to circumvent problems with endogenous alkaline phosphatase. In these cases, endogenous peroxidase was inhibited by 30-min incubation in methanol (0.06% H202) before blocking with normal goat serum. Finally, the slides were counterstained with hemalaum and mounted with glycerinelgelatin.
Results

Speczlfi'c Binahg of BGP MAb 4DlK2
The specificity of MAb 4DllC2 for CD66a has been established in previous studies. To further exclude crossreactivity with members of the CEA family, the binding specificity of MAb 4Dl/C2 was investigated by Western blot analysis ( Figure 1 ). In normal colon mucosa and granulocytes, MAb 4DllC2 detected the CD66aspecific antigen corresponding to an Mr of 160,000 (13,14). MAb 4Dl/C2 binds neither to CEA present in normal colon mucosa nor to additional members of the CD66 cluster present in membrane extracts of granulocytes. To exclude that MAb 4D1/C2 crossreacts with CEA under the experimental conditions used for immunohistochemical staining, binding of MAb 4DllC2 and of the CEAspecific MAb T84.66 to HeLa cells transfected with a CEA cDNA was tested. Staining reactions were completely negative for MAb 4DllC2, whereas MAb T84.66 showed a strong, evenly distributed cytoplasmic staining (not shown).
Immunohistochemzitry
Both MAbs, 4Dl/C2 specific for CD66a and T84.66 specific for CEA, worked well in immunohistochemistry with formalin-fixed cells and tissues. The staining results obtained with these antibodies are summarized in 'Igble 1. In liver sections, MAb 4DllC2 stained hepatocytes at the bile canaliculi ( Figure 2A ). This staining pattern is consistent with the pattern reported by Koelma et al. (21) . who used a crossreactive anti-CEA antibody. In addition, epithelia of bile ducts were also marked moderately at their apical surface. In non-squamous, non-transitional epithelia, the apical membrane binding pattern was very characteristic for immunohistochemistry, with 4DI/C2 in organs of the gastrointestinal tract (Figures 2B and  2C) . pancreas, kidney (Figure 2G) , female breast, uterine cervix, endometrium ( Figure 2E ), and prostate (see Table 1 for details). The location of CEA as revealed by the CEA-specific MAb T84.66 was consistent with results reported previously (22) (23) (24) . With MAb 4Dl/C2 the metaplastic squamous epithelium of the uterine portio displayed a membranous staining most pronounced in superficial layers ( Figure 2F ), which was more marked with MAb T84.66, the latter also extending into the adjacent vaginal epithelium. The membranous staining pattern was also observed in the squamous epithelium of the esophagx when MAb T84.66 was applied. With both MAbs, 4D1/C2 and T84.66, the transitional epithelium of the renal pelvis and the urinary bladder showed moderate to strong membranous staining of the superficial and intermediate layers.
Interestingly, a strong immunohistochemical reaction with MAb 4 D K 2 could also be demonstrated in endothelia of a variety of organs. Placental vessels (arteries, capillaries, and veins) showed strong staining of virtually every endothelial cell, as did the capillaries of the renal glomeruli, vasa recta of the kidney, and adrenal sinusoids. In endometrium, pancreatic islands, prostate, and active regions of the thyroid, some small vessels were strongly stained.
Among hematopoetic cells, granulocytes have been recognized previously as a major site of CD66a by biochemical and immunochemical methods (14) . Application of MAb 4 D K 2 to bone marrow sections enabled us to determine that their precursors acquire CD66a at the level of the myelocyte. Lymphoid and hematopoetic cells other than myeloid remained free of any staining with MAb 4DlIC2. Lung and bronchi, ovaries, and testes were also studied but showed staining reactions neither with MAb 4DlIC2 norwith MAb T84.66
Discussion
In the present study. the expression of CD66a. the human homologue of rat Cell-CAM. was analyzed by immunohistochemical methods. To the authors' best knowledge. this is the first report on the tissue location of CD66a based on a specific MAb. The successful location of CD66a was made p i b l e by the use of the CD66a MAb 4DlIC2. The specificity of this MAb for CD66a has been analyzed in detail. (a) In enzyme immunoassays, the binding to CD66a isolated from human bile is inhibited by neither CEA nor CD66c (NCA-5OIBO) (13). (b) As shown previously. only CD66a was bound by MAb 4DlIC2 among the antigens of the female reproductive system. Strong apical staining for CD66a was found in the CD66 cluster present in granulocyte membranes. No binding to the granulocyte antigens CD66b and CD66c was observed (14) . (c) MAb4DllC2 was exchanged during the CD66CD67 cluster workshop which was part of the Vth lntemational Workshop and Conference on Human Leukocyte Differentiation Antigens.
In immunoprecipitation experiments, the only antigen precipitated from granulocyte membranes by MAb 4DllC2 corresponded to CD66a. Furthermore, binding of CD66 MAbs to transfectants expressing a variety of CD66 antigens (CD66a. CD66b. CD66c. CD66d. CEA. CGM7) was evaluated. MAb 4DllC2 was the only MAb binding exclusively to the CD66a transfectant (15) . Lack of binding to a CEA transfectant was confirmed in the present study.
Our results indicate that CD66a is expressed in a variety of epithelial tissues, in endothelial cells, and in cells of the myeloid lineage. Among the organs of the gastrointestinal tract. well-defined CD66a staining of apical membranes was obsemd in esophageal glands, enterocytes, the surface epithelium of the colon, to a lesser extent in the goblet cells of the crypts. in the large and small pancreatic ducts, and in gallbladder. At these locations. all of the cells lining the lumina scored positive. In the liver CD66a was stained in bile ducts in an apical membranous fashion and in hepatocytes. which showed membranous staining along the bile canaliculi but not along their membranes abutting the spaces of Disse. In the stomach, CD66a could not be demonstrated. CEA staining was along apical membranes. too, exhibiting a different organ distribution, however, with positivity in the epithelium of the stomach, the colon, and in small foci in large pancreatic ducts. In the kidney the epithelium of the proximal tubules showcd strong CD66a staining of apical membranes; distal tubule. in contrast. remained negative. No CEA staining could be demonstrated in the kidney. The transitional epithelium of the renal pelvis and the urinary bladder displayed a moderate membranous staining both for CD66a and CEA, with accentuation in superficial layers. In the prostate there was strong apical membranous staining reaction for CD66a in prismatic or cylindric epithelia. which remained faint in atrophic epithelia. CEA staining was found in sparse foci of prismatic or hyperplastic epithelia. Among the organs of the female reproductive system, strong apical staining for CD66a was found in the mammary duct epithelium, in the endometrium, and in the cervical epithelium. The squamous epithelium of the portio exhibited membranous CD66a and CEA immunoreactivity.
Among the organs tested, CD66a staining of endothelia was confined to glomeruli and vasa recta of the kidney, placenta. endometrium, adrenal sinusoids, pancreatic islets, and active regions of the thyroid.
The immunohistochemical data presented here support our previous findings that CD66a is expressed in granulocytes (14) . Although cells of the erythroid lineage and megakaryocytes were negative for CD66a. the antigen could bc demonstrated in cells of the myelopoetic lineage up to the level of the myelocyte.
There is a remarkable coincidence between the location of CD66a in human tissues and of the rat counterpart. Cell-CAM, in rat tissues (10.1 1) . For example. in the kidney, Cell-CAM and CD66a are well expressed in the proximal but not the distal tubules. Thecapillaries of the glomeruli and the vasa recta staining positive both for CD66a and Cell-CAM. Furthermore, a coincidence of expression of CD66a and Cell-CAM is found at the surface epithelium of the In their report, the authors attributed the positive reaction in the bowel to a crossreaction of their antiserum with NCA. However, we clearly show that both the large and small intestine produce authentic CD66a (BGP).
The wide tissue distribution of CD66a does not provide an immediate clue to biological function. On the basis of trarisfection studies, the homology between CD66a and Cell-CAM, and the putative interaction of CD66a with E-selectin, it has been postulated that CD66a may function as a cell adhesion molecule in vivo. Some findings are in favor of a function as cell adhesion molecule, whereas other findings appear not to support this view. In epithe-lia, the location of CD66a at the apical cell poles appears to exclude a cell-adhesive function. For Cell-CAM found at identical sites in the corresponding rat tissues, it has been suggested that the adhesion molecule may be involved in the organization of microvilli (1 1,2 5 ) . An alternative, although not necessarily exclusive, hypothesis is based on the location and the in vitro interaction of members of the CD66 cluster. Thus far, each of the members of the CD66 cluster for which data on the epithelial location are available has been located to the glycocalyx of epithelial cells (26) . Considering a homophilic and heterophilic interaction of molecules of the CD66 cluster at this site, these adhesion molecules may guide the structure of the glycocalyx. However, we would not exclude that CD66a mediates cell adhesion in those epithelia where the CD66a MAb bound to the apical cell poles only, since the CD66a epitope recognized by our MAb may be masked at adjacent lateral or basal cell membranes because of the interaction with its binding partner(s). The assumption is supported by results reported for adult rat hepatocytes. In these cells, Cell-CAM expressed in the lateral membranes did not bind antibodies unless the tissue was mechanically dissociated (27) .
Although the function of CD66a as an epithelial cell adhesion molecule in vivo is still circumstantial and alternative, although not exclusive, hypotheses on its function have been put forward. Recent experiments indicate that the loss of CD66a in tumor tissues is of great functional significance. Expression of CD66a is downregulated in the great majority of human colorectal carcinomas (28). Similarly, Cell-CAM or its murine homologue have been reported to be downregulated in hepatocellular carcinomas in rats (29, 30) and in colorectal carcinomas in mice (31), respectively. Very recently, Hsie and co-workers ( 3 2 ) transfected a Cell-CAM cDNA into a tumorigenic human prostate cancer cell line. Transfected clones showed significantly lower growth rates, reduced anchorageindependent growth, and less tumorigenicity in vivo than control cells.
The expression of CD66a by endothelial cells at selective sites may be of functional significance and could provide a clue to biological function. Among the tissues tested, some of those expressing CD66a were hormone-dependent. Particularly prominent staining for CD66a was observed in endothelial cells of endometrial capillaries and of the small arteries, venules, and capillaries of the placenta. Because both endometrium and placenta actively proliferate in response to hormonal stimulation, the expression of CD66a may be related to the formation of new blood vessels. Although a potential role for CD66a in angiogenesis is speculative at present, some recent findings are in favor of this assumption. On granulocytes, CD66a has been reported to be the major carrier of sialyl LeX carbohydrate groups that act as ligands for E-selectin ( 4 ) . On the basis of competition experiments, Kuijpers et al. ( 5 ) suggested that CD66a may function as a ligand for E-selectin. According to our recent results (unpublished), granulocyte CD66a indeed binds E-selectin. In an in vitro model of angiogenesis, tube formation was inhibited by antibodies against sialyl LeX oligosaccharides or E-selectin, respectively (33). Because endothelial CD66a may be a carrier of sialyl Lex groups, as reported for granulocyte CD66a, it is a candidate adhesion molecule involved in angiogenesis. In this context, it is interesting that Cell-CAM is transiently expressed very specifically in contact areas between endothelial cells and pericytes during vascularization of the central nervous system ( 3 4 ) .
The expression of CD66a in epithelial of steroid hormonedependent tissues such as endometrium, as well as in mammary and prostatic epithelium, is of particular interest. These epithelia undergo well-defined morphogenetic programs in response to the respective hormonal stimuli. There is experimental evidence that the expression of Cell-CAM is regulated by steroids (32,35) . Because Cell-CAM is the rat homologue of CD66a, the expression of CD66a in hormone-dependent tissues similarly may be under hormonal control.
In conclusion, the expression of CD66a by epithelial, endothelial, and myeloid cells is difficult to explain by one unifying theory. Possibly CD66a exerts a variety of functions. In addition to cell adhesion, other functions have been attributed to CD66a and its rat and murine counterparts, such as binding of microorganisms (36,37), enzymatic ecto-ATPase activity (6), and transport of bile  salts (38,39) . The results of the present study certainly will stimulate experiments that ultimately should lead to a better understanding of the functions of CD66a in normal development, angiogenesis, defense, and malignant disease.
